Search Results 161-170 of 13315 for monoclonal antibody

  1. Infectious Diseases - Overview - Mayo Clinic

    Mayo Clinic was a worldwide leader in using monoclonal antibody therapy. This therapy significantly reduced the hospitalization rate and decreased mortality of ...

  2. Clinical trials - Oncology (Medical)

    Mosunetuzumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... antibodies and the factors that may ...

  3. A Study to Compare Nivolumab or Brentuximab Vedotin Plus Combination Chemotherapy to Treat Patients with Newly-diagnosed Stage III-IV Classic Hodgkin Lymphoma - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as ... Brentuximab vedotin is a monoclonal antibody, brentuximab, linked to a toxic agent called vedotin.

  4. Clinical trials - Oncology (Medical)

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  5. Hematology - Clinical trials

    Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...

  6. Medical Research & Education - Mayo Clinic News Network

    Monoclonal antibody therapy for COVID-19 safe for transplant patients featured image. COVID-19. Monoclonal antibody therapy for COVID-19 safe for transplant ...

  7. Testing Docetaxel-Cetuximab Or The Addition Of An Immunotherapy Drug, Atezolizumab, To The Usual Chemotherapy And Radiation Therapy In High-Risk Head And Neck Cancer - Mayo Clinic

    Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as ...

  8. Clinical trials - Oncology (Medical)

    Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...

  9. Multiple sclerosis - Diagnosis and treatment - Mayo Clinic

    This treatment is a monoclonal antibody that decreases annual relapse rates and demonstrates MRI benefits. This medicine helps reduce relapses of MS by ...

  10. Hodgkin Lymphoma (Hodgkin Disease) Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as ipilimumab and nivolumab, may interfere with the ability of cancer cells to grow and spread. Brentuximab vedotin is a combining ...